THC Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q1 2012 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
THC Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q1 2012 to Q2 2023.
  • THC Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending July 31, 2023 was $8.07M, a 1.02% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $8.07M +$81.2K +1.02% Jul 31, 2023 10-K 2024-02-26
Q2 2022 $7.99M +$319K +4.16% Jul 31, 2022 10-K 2024-02-26
Q2 2021 $7.67M +$396K +5.44% Jul 31, 2021 10-K 2022-11-25
Q2 2020 $7.27M +$8.95M Jul 31, 2020 10-K 2022-03-31
Q2 2019 -$1.67M +$35.2K +2.06% Jul 31, 2019 10-K/A 2019-11-18
Q2 2018 -$1.71M Jul 31, 2018 10-K/A 2019-11-18
Q1 2014 $669K +$506K +310% Apr 30, 2014 10-Q 2014-06-12
Q4 2013 $640K +$484K +309% Jan 31, 2014 10-Q 2014-06-12
Q3 2013 $592K +$452K +325% Oct 31, 2013 10-Q 2014-06-11
Q2 2013 $517K +$385K +291% Jul 31, 2013 10-Q 2014-06-12
Q1 2013 $163K -$354K -68.4% Apr 30, 2013 10-Q 2013-06-11
Q4 2012 $156K Jan 31, 2013 10-Q 2013-03-21
Q3 2012 $139K Oct 31, 2012 10-Q 2012-12-14
Q2 2012 $132K Jul 31, 2012 10-K 2014-06-09
Q1 2012 $517K Mar 14, 2012 10-Q 2014-06-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.